Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays
Sign Up to like & getrecommendations! Published in 2018 at "Scandinavian Journal of Clinical and Laboratory Investigation"
DOI: 10.1080/00365513.2018.1522664
Abstract: Abstract Edoxaban is an oral direct factor Xa inhibitor for prophylaxis and treatment of thromboembolic disorders. The effects on common coagulation assays are clinically valuable information and in certain clinical situations a quick assessment of… read more here.
Keywords: coagulation; anti assays; coagulation assays; oral direct ... See more keywords
Anti-Xa assays: What is their role today in antithrombotic therapy?
Sign Up to like & getrecommendations! Published in 2019 at "Cleveland Clinic Journal of Medicine"
DOI: 10.3949/ccjm.86a.18029
Abstract: Although some suggest anti-Xa assays should be the preferred method for monitoring intravenous unfractionated heparin therapy, which method is best is unknown owing to the lack of large randomized controlled trials correlating different assays with… read more here.
Keywords: assays role; anti assays; today antithrombotic; role today ... See more keywords